Kelly D - Search Results

1

Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.

Hörmannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Hölzlwimmer G, Haller D. Hörmannsperger G, et al. Among authors: kelly d. J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S10-5. doi: 10.1097/MCG.0b013e3181e102c1. J Clin Gastroenterol. 2010. PMID: 20562631

2

Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Hoermannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Hölzlwimmer G, Laschinger M, Haller D. Hoermannsperger G, et al. Among authors: kelly d. PLoS One. 2009;4(2):e4365. doi: 10.1371/journal.pone.0004365. Epub 2009 Feb 6. PLoS One. 2009. PMID: 19197385 Free PMC article.

3

Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease.

Reiff C, Delday M, Rucklidge G, Reid M, Duncan G, Wohlgemuth S, Hörmannsperger G, Loh G, Blaut M, Collie-Duguid E, Haller D, Kelly D. Reiff C, et al. Among authors: kelly d. Inflamm Bowel Dis. 2009 Nov;15(11):1721-36. doi: 10.1002/ibd.20999. Inflamm Bowel Dis. 2009. PMID: 19639558

4

Inflammatory bowel disease, gut bacteria and probiotic therapy.

Reiff C, Kelly D. Reiff C, et al. Among authors: kelly d. Int J Med Microbiol. 2010 Jan;300(1):25-33. doi: 10.1016/j.ijmm.2009.08.004. Epub 2009 Oct 2. Int J Med Microbiol. 2010. PMID: 19800289 Review.

5

Expression of heparan sulfate proteoglycans in murine models of experimental colitis.

Patterson AM, Delday MI, van Kuppevelt TH, Loh G, Blaut M, Haller D, Grant G, Kelly D. Patterson AM, et al. Among authors: kelly d. Inflamm Bowel Dis. 2012 Jun;18(6):1112-26. doi: 10.1002/ibd.21879. Epub 2011 Oct 10. Inflamm Bowel Dis. 2012. PMID: 21987406

6

Microbiome and immunological interactions.

Kelly D, Mulder IE. Kelly D, et al. Nutr Rev. 2012 Aug;70 Suppl 1:S18-30. doi: 10.1111/j.1753-4887.2012.00498.x. Nutr Rev. 2012. PMID: 22861803 Review.

7

Microbes and microbial effector molecules in treatment of inflammatory disorders.

Kelly D, Delday MI, Mulder I. Kelly D, et al. Immunol Rev. 2012 Jan;245(1):27-44. doi: 10.1111/j.1600-065X.2011.01079.x. Immunol Rev. 2012. PMID: 22168412 Review.

8

Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces.

Mulder IE, Schmidt B, Stokes CR, Lewis M, Bailey M, Aminov RI, Prosser JI, Gill BP, Pluske JR, Mayer CD, Musk CC, Kelly D. Mulder IE, et al. Among authors: kelly d. BMC Biol. 2009 Nov 20;7:79. doi: 10.1186/1741-7007-7-79. BMC Biol. 2009. PMID: 19930542 Free PMC article.

9

Gut microbiota and GI health and disease.

Kelly D, Mulder IE. Kelly D, et al. J Pediatr Gastroenterol Nutr. 2011 Dec;53 Suppl 2:S32-4. J Pediatr Gastroenterol Nutr. 2011. PMID: 22235463 Review. No abstract available.

10

Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.

Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS. Vijay-Kumar M, et al. Among authors: kelly d. Am J Pathol. 2006 Nov;169(5):1686-700. doi: 10.2353/ajpath.2006.060345. Am J Pathol. 2006. PMID: 17071592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,250 results

Search Page

Filters